Linear Mixed-Effect Modelling of Antisaccades in Parkinson’s Disease and Progressive Supranuclear Palsy
Objective: This study aims to investigate variations in antisaccade parameters (latency, damping ratio, peak velocity, and amplitude) among different stages of Parkinson's Disease (PD), Progressive…IPSC-derived Cortical Neurons from Parkinson’s Patients with VPS35 Mutation show Defects in Synapto- and Neurogenesis
Objective: Investigate whether the Parkinson’s disease (PD) VPS35 D620N mutation leads to synaptic dysfunction in human cortical iPSC-derived neurons. Background: Early presynaptic dysfunction and cortico-striatal…Enviromental Risk Factors for Parkinson’s Disease in the Nigeria Parkinson’s Disease Research Network
Objective: To determine the risk factors associated with Parkinson’s disease (PD) development in the Nigerian PD Research (NPDR) cohort Background: PD is widely believed to…Effect of Diabetes Mellitus on the Phenotype of Parkinson’s Disease
Objective: In this study, we aim to investigate whether Type 2 diabetes (T2DM) influences the phenotype of Parkinson’s disease (PD). Background: In PD, T2DM may…EMPOWER-PD: Testing and evaluation of an 8-week co-created Self-management program tailored People with Parkinson`s disease and their caregivers in an interventional follow-up study
Objective: This study aims to test a 8-week self-management program, developed collaboratively with People with PD (PwP), caregivers, healthcare professionals and other stakeholders using a…Increasing access to Deep Brain Stimulation for an underserved patient population: A retrospective cohort from an urban hospital in a diverse county in the USA.
Objective: To understand whether the presence of a Bilingual Movement Disorder specialist increases access to Deep Brain Stimulation (DBS) for an underserved patient population. Background:…Path To Prevention (P2P) Therapeutics Platform Trial in Stage 2B Neuronal Alpha-Synuclein Disease: Study Update
Objective: To describe the study design and timeline of the first interventional study in Neuronal α-Synuclein Disease (NSD). Background: P2P is a platform, Phase 2…Establishing α-Synuclein Seeding Activity in Saliva as a Noninvasive Diagnostic Biomarker for Parkinson’s Disease
Objective: To establish α-synuclein seeding activity in saliva as a noninvasive diagnostic biomarker for Parkinson’s disease (PD). Background: PD is the second most common neurodegenerative…Influence of immigration on Parkinson’s disease: analysis of clinical presentation.
Objective: To analyze the epidemiological and clinical presentation in our immigrants patients with Parkinson’s disease (PD) from our reference population in Barcelona, Spain. Background: In…Cognitive Side Effects to Initial Levodopa Exposure as a “Red Flag”: A Retrospective Study
Objective: To assess if presence of cognitive side effects during an initial levodopa trial suggests the ultimate diagnosis of atypical Parkinson (APD) vs Parkinson disease…
- « Previous Page
- 1
- …
- 184
- 185
- 186
- 187
- 188
- …
- 436
- Next Page »